Conversation with The Cancer Letter Trump’s plans for Inova reach across the Washington Beltway, through Virginia—and beyond November 10, 2017Vol.43 No.42By Paul Goldberg
Drugs & Targets FDA approves Kite’s CAR-T cell therapy; another win for NCI’s intramural program November 07, 2017Vol.40 No.09By Matthew Bin Han Ong
Pfizer, Astellas report positive results from trial of Xtandi in non-metastatic castration-resistant disease November 07, 2017Vol.40 No.09
Cleveland Clinic study: timing of melanoma diagnosis, treatment critical to survival November 07, 2017Vol.40 No.09
Local radiation provides comparable control of brain metastases compared to surgery November 07, 2017Vol.40 No.09
Trastuzumab for HER-2-expressing tumors needn’t delay breast reconstruction November 07, 2017Vol.40 No.09
Researchers confirm IASLC proposed characterization of uncertain R Status R(un), prognosis between R0 and R1 November 07, 2017Vol.40 No.09
